doi: 10.1016/j.isci.2024.109784 Roland BC, Lee D, Miller LS, Vegesna A, Yolken R, Severance E, et al
Together, well build a safe, science-backed plan that transforms not just how you look, but how you live.
Incidence rate ratios (IRRs) of malignancy in patients with type 2 diabetes mellitus (DM): glucagon-like peptide-1 receptor agonist (GLP-1 RA) group vs
7 Discussion GLP-1 RAs have shown effects beyond their initial application in managing T2DM
Read more Discover why Wegovy causes nausea and get expert tips to manage side effects safely and effectively
Methods We obtained the data from PubMed, Scopus, Embase, and Web of Science for all eligible studies, including clinical trials (RCT) and cohorts comparing GLP-1 RAs to placebo or other hypoglycemic agents in patients with HFpEF published until December 31st, 2024